ConductScience.org, home

Paper42525317

Rutin as a multi-target anti-inflammatory phytochemical in arthritic disorders: pharmacological mechanisms and therapeutic potential.

Nazir MM and 1 other. Inflammopharmacology, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Rutin as a multi-target anti-inflammatory phytochemical in arthritic disorders: pharmacological mechanisms and therapeutic potential. Papers, record 42525317. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42525317

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Rutin as a multi-target anti-inflammatory phytochemical in arthritic disorders: pharmacological mechanisms and therapeutic potential.
PubMed
Journal
Inflammopharmacology
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-11-05
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nazir MMMuhammad Muzammil
2Ashraf AAsmahttps://orcid.org/0000-0001-7026-670X

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
RutinMajor topic
Anti-Inflammatory AgentsMajor topic
PhytochemicalsMajor topic
ArthritisMajor topic
Humans
Animals
Arthritis, Rheumatoid
Osteoarthritis
Arthritis, Gouty

Source PubMed

Download CSV of topics

References53

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132620467Role of Nrf2 in rheumatoid arthritis.Curr Res Transl Med2020https://conductscience.org/library/papers/32620467PubMed
234824210The JAK/STAT signaling pathway: from bench to clinic.Signal Transduct Target Ther2021https://conductscience.org/library/papers/34824210PubMed
340932869Xuetongsu attenuates synovial inflammation in rheumatoid arthritis by inhibiting the IL-23/IL-17/NF-κB inflammatory axis.Front Pharmacol2025https://conductscience.org/library/papers/40932869PubMed
434987201Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach.Nat Rev Rheumatol2022https://conductscience.org/library/papers/34987201PubMed
535588172Rutin Inhibits the Progression of Osteoarthritis Through CBS-Mediated RhoA/ROCK Signaling.DNA Cell Biol2022https://conductscience.org/library/papers/35588172PubMed
641247262Xuetongsu attenuates bone destruction in rheumatoid arthritis by suppressing RANKL/RANK/NFATc1 pathway to inhibit osteoclastogenesis and bone resorption.Bone Joint Res2025https://conductscience.org/library/papers/41247262PubMed
741132114Natural-based antioxidants in cosmeceuticals: Extraction, bioavailability and skin ageing applications.Int J Cosmet Sci2026https://conductscience.org/library/papers/41132114PubMed
834046688Clinical, radiologic and serologic profile of patients with interstitial pneumonia with autoimmune features: a cross-sectional study.Rheumatol Int2022https://conductscience.org/library/papers/34046688PubMed
935055087Rheumatoid Arthritis: Pathogenic Roles of Diverse Immune Cells.Int J Mol Sci2022https://conductscience.org/library/papers/35055087PubMed
1028467992Rutin Attenuates Oxidative Stress and Proinflammatory Cytokine Level in Adjuvant Induced Rheumatoid Arthritis via Inhibition of NF-κB.Pharmacology2017https://conductscience.org/library/papers/28467992PubMed
1137938494JAK-STAT signaling in inflammation and stress-related diseases: implications for therapeutic interventions.Mol Biomed2023https://conductscience.org/library/papers/37938494PubMed
1235360183Ingredients of a Natural Oral Nutritional Supplement and Their Role in the Treatment of Osteoarthritis.Clin Med Insights Arthritis Musculoskelet Disord2022https://conductscience.org/library/papers/35360183PubMed
1340529506Molecular mechanisms of neuroprotective effect of rutin.Front Pharmacol2025https://conductscience.org/library/papers/40529506PubMed
1425219641Oleuropein or rutin consumption decreases the spontaneous development of osteoarthritis in the Hartley guinea pig.Osteoarthritis Cartilage2015https://conductscience.org/library/papers/25219641PubMed
1541596127Emerging Therapeutic Strategies for Nrf2-Associated Skin Disorders: From Photoaging to Autoimmunity.Antioxidants (Basel)2026https://conductscience.org/library/papers/41596127PubMed
1632368038Cyclodextrin-Modified CeO2 Nanoparticles as a Multifunctional Nanozyme for Combinational Therapy of Psoriasis.Int J Nanomedicine2020https://conductscience.org/library/papers/32368038PubMed
1711680812Anti-inflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat.Farmaco2001https://conductscience.org/library/papers/11680812PubMed
1839906613Rutin attenuates complete Freund's adjuvant-induced inflammatory pain in rats.Iran J Basic Med Sci2025https://conductscience.org/library/papers/39906613PubMed
1935254584
Berberis lycium fruit extract and its phytoconstituents berberine and rutin mitigate collagen-CFA-induced arthritis (CIA) via improving GSK3β/STAT/Akt/MAPKs/NF-κB signaling axis mediated oxi-inflammation and joint articular damage in murine model.
Inflammopharmacology2022https://conductscience.org/library/papers/35254584PubMed
2027539668Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis.Nat Rev Rheumatol2016https://conductscience.org/library/papers/27539668PubMed

See all 53 referencesDownload CSV of references

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42525317

GET https://conductscience.org/api/papers/v1/42525317/references?page=2